For example, expression of phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme in the serine biosynthetic pathway (SBP), is upregulated in breast cancer and melanoma due to genomic amplification of the PHGDH locus. Here, PHGDH is linked to breast carcinoma.